In 2023, direct spending within orthopedics, oncology, cardiology, women’s health, behavioral health and nephrology made up 38% of all total medical spending, and 68% of total commercial and Medicare spending, according to a July 22 report from consulting firm McKinsey & Co.
Here is how Medicare and commercial spending changed from 2020 to 2023, by specialty:
| Total Medicare and commercial spending | |||
| Specialty | 2020 spending (in billions) | 2023 spending (in billions) | Compound annual growth rate |
| Orthopedics | $189 | $245 | 9.1% |
| Oncology | $147 | $190 | 9.1% |
| Cardiology | $83 | $104 | 7.7% |
| Women’s health | $49 | $76 | 16.0% |
| Behavioral health | $49 | $75 | 15.0% |
| Nephrology | $39 | $34 | -4.3% |
| All other spending | $960 | $1,171 | 6.8% |
The healthcare industry has the potential to save $100 billion per year by utilizing value-based care models within specialty care, the report said.
Here are the potential savings associated with value-based care, by specialty:
| 2023 Total cost of care and potential savings | |||
| Specialty | Total cost of specialty care (in billions) | Other spending for same patients (in billions) | Potential annual savings (in billions) |
| Orthopedics | $245 | $655 | $35-$45 |
| Oncology | $190 | $335 | $50-$60 |
| Cardiology | $104 | $467 | $15-$20 |
| Women’s health | $76 | $129 | $5-$10 |
| Behavioral health | $75 | $224 | $10-$15 |
| Nephrology | $34 | $141 | $30-$40 |
Currently, value-based-care models cover about 28% of patients in nephrology, 20% in orthopedics, and 5% or less in cardiology, oncology, women’s health and behavioral health.
The report identified four “levers” for potential savings while maintaining high-quality care and favorable outcomes:
- Consistent, effective and timely diagnostics
- Cost-effective therapeutic alternatives
- Lower-cost sites of care when clinically appropriate
- Prevention of complications from procedures or acute events through clinical best practices and follow-ups
The report also identified four industry “archetypes” that can be employed to influence care value:
- Site-agnostic wraparound services
- Outpatient-focused integrated care
- Treatment pathway navigator
- Digital health innovator
Read the full report here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
